The average cost of a single phase 3 clinical trial is $19,9M
Key cost drivers of pharmaceutical clinical trials in the United States.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Mar 2019 – Jun 2025Where it's discussed
-
X / Twitter22 posts
-
News15 articles
-
Blogs4 articles
-
YouTube2 videos
-
Facebook2 posts
-
Bluesky1 posts
AI synopsis
What people are saying
The discussions reflect strong interest and engagement, with examples such as citing specific trial costs, mentioning research sources, and recommending videos to better understand the financial and scientific aspects. The tone combines curiosity and analytical reflection, highlighting how the article's focus on cost drivers informs broader conversations on drug development and healthcare costs.
Most discussions acknowledge the significance of the article's insights into cost drivers and clinical trial expenses, indicating general agreement.
Many participants show high interest by referencing specific cost figures, related videos, and the importance of understanding pharmaceutical research finances.
Posts involve detailed references to research sources, videos, and conceptual discussions, demonstrating deep engagement with the topic.
While some posts suggest the information can influence decision-making or raise awareness, overall impact appears moderate due to the technical nature of the data.
Abstract in brief
- The study highlights that the main factors influencing the high costs of pharmaceutical clinical trials in the US are clinical procedure expenses, administrative staff, and site monitoring costs, with costs varying significantly depending on the therapeutic area and trial phase.
- Clinical trial costs increase notably with the phase, with Phase 1 costs starting around $1.4 million and rising to as much as nearly $5.3 million in Phase 3, depending on the therapeutic area.
- Understanding these key cost drivers is essential because the rising costs can discourage drug companies from conducting trials, which may limit patient access to new treatments and impact public health.
Top posts
Most liked on X and BlueskyInflation + depending on the specific case, these numbers can be even higher. Sources here: https://t.co/AgyZgH8xlX https://t.co/hvEt5UWZL4
Philosophers of medicine, can you please react to this video https://t.co/Q1NoOx9Ik8
a highly useful look on why so few high quality cosmetic clinical trials exist, and how you can critically examine related evidence to reach a conclusion even without them. https://t.co/kUKZ6PzlSm
@RaraSensei https://t.co/Myim6fbzZ6 I highly recommend watching this woman's video on the topic. It gives you a brief rundown on the chemical mechanism behind retinol skin care and the various forms you can get it in and the pros and cons of each. Only protip from me: you can't do it daily
@gabrieln___ @hbredda @andregordon73 @jlbraga @fernandocluiz @cesaralpaiva @femisapien_z Se tiver curiosidade de mergulhar mais fundo nos custos e probs pharma: 1) custos: Key cost drivers of pharmaceutical clinical trials in the United States (Sertakya et al. 2016) 2) probabilidades: Clinical development success rates for investigational drugs (Hay et al. 2014)
All mentions
Evaluating the Effectiveness of Retinol in Skincare Products
Does retinol in skincare have scientific backing? Scientifically, the evidence is mixed. This video explores the research and discusses why some claim retinol may not be as effective as believed while examining the…
Understanding Costs and Processes in Drug Development
Drug development involves bringing a new pharmaceutical to market through preclinical research, regulatory approval, and clinical trials. Major cost drivers include clinical procedures, staff, and site monitoring, with…
bahan #sebwapengingat https://t.co/IGyKRvl0zp
Inflation + depending on the specific case, these numbers can be even higher. Sources here: https://t.co/AgyZgH8xlX https://t.co/hvEt5UWZL4
@elmarkbgk @vlucasrocha Na verdade, cosméticos requerem menos estudos científicos para serem liberados. Isso quer dizer que não funcionam? Não necessariamente. Todos funcionam? Também não. Lab Muffin no Youtube tem um vídeo muito bom explicando sobre. https://t.co/TKWbtcBnyP
https://t.co/VspSSlPLH0 คนไทยมานั่งเถียงกันเรื่องเรตินอลฟอร์มสกินแคร์ มาฟังจากคนรู้จริงๆแบบจิงๆดีกว่าค่า not หมอ not อินฟลู
Bu ablanın konu üzerine vidyosu güzelmiş https://t.co/sZqwRQ75VJ
@RaraSensei https://t.co/Myim6fbzZ6 I highly recommend watching this woman's video on the topic. It gives you a brief rundown on the chemical mechanism behind retinol skin care and the various forms you can get it in and the pros and cons of each. Only protip from me: you can't do it daily
y’a pleins de facteurs qui expliquent pourquoi les marques font pas + d’efforts (légaux, financiers, etc) de ce côté là labmuffin a fait une excellente vidéo dessus en partant de l’exemple de notre sacro-saint Rétinol : https://t.co/ZWnDWBjxkx
a highly useful look on why so few high quality cosmetic clinical trials exist, and how you can critically examine related evidence to reach a conclusion even without them. https://t.co/kUKZ6PzlSm
Niat dengerin ini biar cepet ngantuk, taunya menarik malah bikin mikir
muy interesante: Does retinol in skincare even work? https://t.co/7V48o3kGnb
Philosophers of medicine, can you please react to this video https://t.co/Q1NoOx9Ik8
I think philosophers of medicine should watch and react to this video youtu.be/e6Z5Vr7uSiA?...
If you have any interest in skin care, watch this. She's probably the best skinfluencer and an actual PhD cosmetic chemist. https://t.co/MRdIR1zKi8
@kevinpayneLD21 @willhumble_az @utilityreporter @AZDHS @JenLongdon @TJShopeforAZ https://t.co/AaYvsVsMJ1 In a report submitted to the U.S. Department of Health and Human Services the AVERAGE cost of phase 1, 2, and 3 clinical trials is around $4, $13, and $20 million respectively. Some phase 3 trials were up to $59 million.
These costs shared above were estimated in the analysis published by Dr. Aylin Sertkaya and colleagues in 2016. https://t.co/P1BRTSNc0w
@alyssamvance Check out https://t.co/T2vrr2F8sW and https://t.co/CwNNCyJU3d for the grinding minutiae (the infographic has a separate source). https://t.co/4ZCBlQCfHd
RT @triallofficial: The average cost of a single phase 3 clinical trial is $19,9M
RT @triallofficial: The average cost of a single phase 3 clinical trial is $19,9M
The average cost of a single phase 3 clinical trial is $19,9M
@TomiHaataja @joonahermanni (Ja muut sen synteesin luvut eri vaiheille ilmeisesti tästä https://t.co/QkBdH7lGeU)
@ASlavitt https://t.co/qJIjAncEqA
The heavy cost burden of #clinicalresearch can play a big role in the choice of #pharmaceutical companies to move forward with new drug innovations. Moligo Technologies has opened new possibilities through it's cost-effective way to #synthesize pure #DNA. https://t.co/rFd1AMwgDr https://t.co/ufrjy3GVHx
@gabrieln___ @hbredda @andregordon73 @jlbraga @fernandocluiz @cesaralpaiva @femisapien_z Se tiver curiosidade de mergulhar mais fundo nos custos e probs pharma: 1) custos: Key cost drivers of pharmaceutical clinical trials in the United States (Sertakya et al. 2016) 2) probabilidades: Clinical development success rates for investigational drugs (Hay et al. 2014)
T
NS
BO
SM
MM
NN
C
K
OH
WH
M